BRAVE ASSET MANAGEMENT INC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 145 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
BRAVE ASSET MANAGEMENT INC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2016$44,000
+2.3%
7,8620.0%0.03%
-3.4%
Q2 2016$43,000
-59.0%
7,862
-44.5%
0.03%
-60.8%
Q1 2016$105,000
+19.3%
14,162
+34.1%
0.07%
+25.4%
Q4 2015$88,000
-7.4%
10,5620.0%0.06%
-19.2%
Q3 2015$95,000
-25.2%
10,5620.0%0.07%
-18.0%
Q2 2015$127,000
+29.6%
10,562
+16.1%
0.09%
+29.0%
Q1 2015$98,0009,1000.07%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2016
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,642,959$25,186,0003.76%
MSD Partners, L.P. 15,151,516$26,061,0002.11%
MSD Partners, L.P. 7,575,758$13,030,0001.05%
MAGNOLIA CAPITAL ADVISORS LLC 418,569$720,0000.61%
STEEL GROVE CAPITAL ADVISORS, LLC 1,080,000$1,858,0000.33%
EAM Investors, LLC 454,625$782,0000.17%
Allred Capital Management, LLC 158,000$271,0000.17%
Boxer Capital, LLC 1,500,000$2,580,0000.14%
GSA CAPITAL PARTNERS LLP 608,037$1,046,0000.14%
CHIRON CAPITAL MANAGEMENT, LLC 116,860$201,0000.14%
View complete list of ZIOPHARM ONCOLOGY INC shareholders